Karthikeyan Ramanujam | Health Professions | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Karthikeyan Ramanujam
ICMR – National Institute of Nutrition, India

Karthikeyan Ramanujam
Affiliation ICMR – National Institute of Nutrition
Country India
Scopus ID 56346958400
Documents 39
Citations 1,961
h-index 20
Subject Area Health Professions
Event Global Innovation Technologist Awards
Google Scholar ID DSsYYYEAAAAJ
Karthikeyan Ramanujam is a Scientist-C affiliated with the Indian Council of Medical Research and the ICMR–National Institute of Nutrition, Hyderabad, India. His scholarly contributions span epidemiology, biostatistics, diarrhoeal disease research, child health, nutrition, and public health analytics. The research portfolio associated with his Scopus profile demonstrates sustained engagement in internationally collaborative health studies focused on low-resource settings and population-based disease surveillance.[1]

The recognition associated with the Innovative Research Award acknowledges contributions to evidence-based public health research, multidisciplinary epidemiological investigations, and global child health studies. His publications in internationally recognized journals including The Lancet Global Health, BMJ Global Health, Clinical Infectious Diseases, and the New England Journal of Medicine have contributed to broader scientific understanding of enteric infections, nutritional health, and disease burden in developing regions.[2][3]

Abstract

The Innovative Research Award profile of Karthikeyan Ramanujam reflects a sustained academic contribution to epidemiology, child nutrition, infectious disease analytics, and public health research. Through collaborative investigations conducted under international and institutional health frameworks, the researcher has contributed to high-impact publications focused on diarrhoeal disease burden, enteropathogen surveillance, child growth outcomes, and nutritional epidemiology in low-resource environments. The scholarly output associated with this profile demonstrates measurable citation impact, interdisciplinary relevance, and substantial engagement in evidence-based public health initiatives.[4]

Keywords

Biostatistics; Epidemiology; Public Health; Child Nutrition; Infectious Diseases; MAL-ED Study; Enteropathogens; Global Health; Disease Surveillance; Nutritional Epidemiology.

Introduction

Global public health research increasingly relies on interdisciplinary collaborations to address infectious disease transmission, childhood nutrition, and epidemiological risk factors across vulnerable populations. Within this context, Karthikeyan Ramanujam has participated in several internationally recognized research initiatives examining the burden of enteric diseases and nutritional deficiencies among children living in resource-constrained regions.[5]

The researcher’s work is closely associated with population-level analyses involving epidemiological surveillance, statistical interpretation of clinical datasets, and longitudinal public health studies. Such investigations contribute to broader healthcare policy discussions and support evidence-driven interventions within global health systems.[6]

Research Profile

According to indexed academic records, Karthikeyan Ramanujam has contributed to 39 scholarly documents with an accumulated citation count exceeding 1,900 citations and an h-index of 20. The research profile demonstrates active participation in collaborative public health investigations involving institutions and researchers from multiple countries.[1]

  • Research specialization includes epidemiology, public health, nutritional science, and biostatistics.
  • Contributions are associated with multinational studies focused on child growth, enteric infections, and environmental enteropathy.
  • Publications appear in peer-reviewed journals with global readership and recognized scientific impact metrics.
  • Research activity demonstrates engagement with evidence-based healthcare analysis and population health methodologies.

Research Contributions

The researcher has contributed to major studies evaluating quantitative molecular diagnostic approaches for identifying enteropathogen-related diarrhoeal diseases among children in low-resource settings. These studies provided insights into disease etiology, pathogen burden, and associated clinical outcomes through advanced molecular diagnostic frameworks.[2]

Additional work explored the relationship between enteropathogen exposure and childhood linear growth outcomes, highlighting associations between repeated infections, nutritional status, and developmental health indicators. The findings contributed to the scientific understanding of environmental enteropathy and pediatric growth impairment.[3]

Research involvement in the MAL-ED birth cohort studies further supported the investigation of intestinal permeability, inflammation pathways, dietary intake patterns, and cognitive development in early childhood populations. These contributions are relevant to both clinical epidemiology and global nutrition policy frameworks.[7]

Publications

Selected publications associated with the research profile include the following high-impact contributions:

  • Platts-Mills JA et al. “Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings.” The Lancet Global Health, 2018.[2]
  • Rogawski ET et al. “Use of quantitative molecular diagnostic methods to investigate the effect of enteropathogen infections on linear growth in children in low-resource settings.” The Lancet Global Health, 2018.[3]
  • Kosek MN et al. “Causal pathways from enteropathogens to environmental enteropathy.” EBioMedicine, 2017.[5]
  • Amour C et al. “Epidemiology and Impact of Campylobacter Infection in Children in 8 Low-Resource Settings.” Clinical Infectious Diseases, 2016.[6]
  • John J et al. “Burden of typhoid and paratyphoid fever in India.” New England Journal of Medicine, 2023.[8]

Research Impact

The academic impact associated with this research profile is reflected through substantial citation performance and participation in influential multinational studies. Citation counts exceeding 1,900 citations indicate consistent scholarly engagement and utilization of the research findings by the broader scientific community.[1]

The integration of epidemiological analytics with nutritional and infectious disease research has supported evidence-based policy discussions related to child health interventions, disease prevention strategies, and healthcare resource allocation in low-income regions. Several publications associated with the profile have become widely referenced contributions within global public health literature.[2][5]

Award Suitability

The Innovative Research Award recognizes scholarly excellence, measurable scientific impact, and contributions that support advancements in research-driven innovation. The academic profile of Karthikeyan Ramanujam aligns with these criteria through sustained involvement in internationally collaborative health studies, impactful publication records, and contributions to epidemiological and nutritional science research.[4]

The demonstrated ability to contribute to multidisciplinary investigations addressing global child health challenges further supports recognition within international academic and scientific award platforms. The combination of citation performance, institutional affiliation, and peer-reviewed publication history reinforces the significance of the researcher’s scientific contributions.[8]

Conclusion

Karthikeyan Ramanujam has established a research profile characterized by collaborative public health scholarship, epidemiological analysis, and evidence-based contributions to global child health research. Through publications addressing enteric infections, nutrition, disease burden, and developmental outcomes, the researcher has contributed to advancing scientific understanding in health professions and epidemiological sciences.

The Innovative Research Award profile recognizes these contributions within the broader context of scientific innovation, multidisciplinary collaboration, and measurable academic impact. The body of work associated with this profile demonstrates continued relevance to international public health research initiatives and healthcare policy development.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Karthikeyan Ramanujam, Author ID 56346958400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56346958400
  2. Platts-Mills JA et al. (2018). Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings. The Lancet Global Health, 6(12), e1309-e1318.
    https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(18)30349-8/fulltext
  3. Rogawski ET et al. (2018). Use of quantitative molecular diagnostic methods to investigate the effect of enteropathogen infections on linear growth in children in low-resource settings. The Lancet Global Health, 6(12), e1319-e1328.
  4. Global Innovation Technologist Awards. (n.d.). Innovative Research Award recognition platform and scientific excellence framework.
    innovationtechnologist.com
  5. Kosek MN et al. (2017). Causal pathways from enteropathogens to environmental enteropathy: findings from the MAL-ED birth cohort study. EBioMedicine, 18, 109-117.
    https://doi.org/10.1016/j.ebiom.2017.02.024
  6. Amour C et al. (2016). Epidemiology and Impact of Campylobacter Infection in Children in 8 Low-Resource Settings: Results From the MAL-ED Study. Clinical Infectious Diseases, 63(9), 1171-1179.
    https://doi.org/10.1093/cid/ciw542
  7. McCormick BJJ et al. (2019). Intestinal permeability and inflammation mediate the association between nutrient density of complementary foods and biochemical measures of micronutrient status in young children. The American Journal of Clinical Nutrition, 110(4), 1015-1025.
    https://www.sciencedirect.com/science/article/pii/S000291652201276X
  8. John J et al. (2023). Burden of typhoid and paratyphoid fever in India. New England Journal of Medicine, 388(16), 1491-1500.
    https://www.nejm.org/doi/full/10.1056/NEJMoa2209449

Mutinda Cleophas Kyama | Medicine and Health Sciences | Research Excellence Award

Published on by Innovation Technologist

Research Excellence Award

Cleophas Mutinda Kyama
Jomo Kenyatta University of Agriculture and Technology, Kenya
Cleophas Mutinda Kyama
Affiliation Jomo Kenyatta University of Agriculture and Technology
Country Kenya
Scopus ID 57216717397
Documents 65
Citations 2,698
h-index 29
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0001-6459-1514

Cleophas Mutinda Kyama is a Kenyan biomedical scientist, clinical cytologist, and academic researcher associated with the Jomo Kenyatta University of Agriculture and Technology (JKUAT). His scholarly contributions span cancer biology, molecular diagnostics, parasitology, toxicology, infectious disease detection, and translational biomedical sciences. His publication record demonstrates sustained engagement in interdisciplinary health science research with applications in oncology, infectious diseases, immunology, and molecular medicine.[1] The researcher has received significant scholarly attention through citations and collaborative biomedical investigations, particularly in cervical cancer diagnostics, phytomedicine, CRISPR-based diagnostic technologies, and antivenom development.[2]

Abstract

The Research Excellence Award recognition article documents the scholarly achievements and biomedical research contributions of Cleophas Mutinda Kyama. His scientific portfolio encompasses molecular diagnostics, oncology, pharmacological investigations, parasitology, immunological research, and translational health sciences. Through peer-reviewed publications, collaborative international research, and laboratory-based innovations, Kyama has contributed to the advancement of diagnostic technologies and therapeutic investigations relevant to public health challenges in Africa and globally.[3] The researcher’s work demonstrates integration of computational biology, molecular docking, in vitro experimentation, and nanotechnology-assisted diagnostics, reflecting contemporary interdisciplinary scientific approaches.[4]

Keywords

Biomedical Sciences; Molecular Diagnostics; Cervical Cancer Research; CRISPR-Cas12a; Oncology; Cytology; Antivenom Research; Pharmacology; Translational Medicine; Public Health Research; Cancer Therapeutics; Computational Biology.

Introduction

Biomedical and translational health sciences have increasingly relied upon interdisciplinary approaches integrating molecular biology, computational modeling, immunology, and experimental medicine. Within this scientific landscape, Cleophas Mutinda Kyama has contributed to research efforts addressing infectious diseases, cancer diagnostics, toxicology, and therapeutic screening technologies.[5] His work has emphasized practical healthcare applications, particularly within African biomedical contexts where diagnostic accessibility and disease management remain major public health priorities.

Kyama’s research trajectory demonstrates sustained engagement in clinically relevant investigations involving HPV-associated cervical cancer screening, SARS-CoV-2 detection systems, phytochemical anticancer studies, and venom toxicology. Several of his investigations combine computational methodologies with laboratory validation, contributing to evidence-based biomedical innovation and translational healthcare research.[6]

Research Profile

Cleophas Mutinda Kyama served at Jomo Kenyatta University of Agriculture and Technology as a Biomedical Scientist and Senior Lecturer in Medical Laboratory Sciences. His academic and professional work has focused on laboratory diagnostics, cytology, cancer biology, molecular therapeutics, and pathogen detection technologies.[1]

The researcher’s Scopus profile reports 65 scholarly documents with 2,698 citations and an h-index of 29, reflecting measurable scientific visibility and sustained citation impact across biomedical disciplines.[1] His work has appeared in journals including PLOS ONE, BMC Complementary Medicine and Therapies, Diagnostics, Toxicon: X, Toxins, and the South African Journal of Botany.

  • Research specialization in molecular diagnostics and biomedical laboratory sciences.
  • Interdisciplinary research combining computational biology and experimental medicine.
  • Published investigations involving oncology, toxicology, parasitology, and virology.
  • Contributions to public health-oriented biomedical innovation.

Research Contributions

Among Kyama’s notable scientific contributions are investigations into cervical cancer therapeutics and molecular screening technologies. His 2025 study in PLOS ONE explored the molecular mechanisms of Solanecio mannii aqueous root extracts against cervical cancer using computational and experimental validation methodologies.[2]

Additional research explored network pharmacology and molecular docking strategies for prostate cancer treatment investigations using Aspilia pluriseta. These studies integrated in vitro analysis with computational biology techniques to evaluate antiproliferative activity and potential therapeutic mechanisms.[3]

Kyama also contributed to advanced infectious disease diagnostics through CRISPR-Cas12a and hybridization chain reaction methodologies for SARS-CoV-2 detection. This work reflected the growing importance of rapid molecular diagnostic systems during global public health emergencies.[4]

In toxicological and immunological sciences, his studies investigated venom lethality, monoclonal antibody development, and antivenom efficacy involving Naja ashei toxins. These investigations contributed to understanding envenomation management and toxin-neutralizing biomedical strategies.[7]

Publications

Selected publications associated with Cleophas Mutinda Kyama include peer-reviewed journal articles, preprints, and translational biomedical studies relevant to oncology, diagnostics, toxicology, and parasitology.

  1. Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer. PLOS ONE (2025).
  2. Network pharmacology, molecular docking, and in vitro study on Aspilia pluriseta against prostate cancer. BMC Complementary Medicine and Therapies (2024).
  3. Application of Hybridization Chain Reaction/CRISPR-Cas12a for the Detection of SARS-CoV-2 Infection. Diagnostics (2023).
  4. Evaluation of lethality and cytotoxic effects induced by Naja ashei venom and efficacy of selected antivenoms in Kenya. Toxicon: X (2022).
  5. Development and Characterization of Anti-Naja ashei Three-Finger Toxins-Specific Monoclonal Antibodies. Toxins (2022).

Research Impact

The scientific impact of Cleophas Mutinda Kyama’s work is reflected through citation metrics, interdisciplinary collaborations, and practical biomedical applications. His investigations into molecular diagnostics and therapeutic evaluation contribute to contemporary discussions surrounding affordable healthcare technologies, precision diagnostics, and evidence-based medicinal research.[4]

Research involving CRISPR-based diagnostics and nanoparticle-assisted detection systems demonstrates alignment with emerging biomedical technologies that support rapid pathogen identification and translational healthcare innovation.[8] Similarly, his toxicological and antivenom studies address healthcare concerns related to snakebite management in endemic regions.

The integration of phytomedicine, computational molecular analysis, and laboratory validation techniques further reflects a multidisciplinary scientific framework capable of supporting future biomedical innovation and collaborative translational research initiatives.[3]

Award Suitability

The scholarly profile of Cleophas Mutinda Kyama demonstrates characteristics associated with international academic recognition and research excellence awards. His documented publication history, citation impact, interdisciplinary biomedical investigations, and sustained engagement in translational health sciences collectively support recognition within the framework of the Global Innovation Technologist Awards.[1]

  • Demonstrated publication productivity in indexed scientific journals.
  • Strong citation impact and measurable academic influence.
  • Contributions to molecular diagnostics and translational medicine.
  • Interdisciplinary biomedical innovation relevant to public health.
  • Research engagement involving computational and experimental methodologies.

Conclusion

Cleophas Mutinda Kyama has established a research profile characterized by interdisciplinary biomedical inquiry, molecular diagnostic innovation, and translational scientific investigations addressing major health challenges. His academic contributions in oncology, toxicology, molecular biology, and infectious disease diagnostics demonstrate sustained scholarly engagement and measurable scientific impact.[5] Through collaborative biomedical research and publication activity, his work contributes to evolving scientific understanding within medicine and health sciences while supporting broader healthcare research objectives relevant to emerging global health priorities.

References

  1. Elsevier. (n.d.). Scopus author details: Cleophas Mutinda Kyama, Author ID 57216717397. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57216717397
  2. Kyama, C. M. et al. (2025). Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer. PLOS ONE.
    https://doi.org/10.1371/journal.pone.0323680
  3. Kyama, C. M. et al. (2024). Network pharmacology, molecular docking, and in vitro study on Aspilia pluriseta against prostate cancer. BMC Complementary Medicine and Therapies.
    https://doi.org/10.1186/s12906-024-04642-8
  4. Kyama, C. M. et al. (2023). Application of Hybridization Chain Reaction/CRISPR-Cas12a for the Detection of SARS-CoV-2 Infection. Diagnostics.
    https://doi.org/10.3390/diagnostics13091644
  5. Jomo Kenyatta University of Agriculture and Technology. (n.d.). Medical Laboratory Sciences and Biomedical Research Activities.
  6. Kyama, C. M. et al. (2022). Expression of the Fab enzymes from Plasmodium falciparum after exposure to Artemisia afra plant extracts. Journal of Parasitic Diseases.
    https://doi.org/10.1007/s12639-022-01537-8
  7. Kyama, C. M. et al. (2022). Development and Characterization of Anti-Naja ashei Three-Finger Toxins-Specific Monoclonal Antibodies. Toxins.
    https://doi.org/10.3390/toxins14040285
  8. Kyama, C. M. et al. (2020). Development of HPV 16/18 E6 oncoprotein paper-based nanokit for enhanced cervical cancer screening.
    https://doi.org/10.1101/2020.04.29.20084459